- Home
- BIVI vs EVGN Comparison
BIVI vs EVGN Comparison
Compare BIVI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- EVGN
- Stock Information
- Founded
- BIVI 2013
- EVGN 1999
- Country
- BIVI United States
- EVGN Israel
- Employees
- BIVI N/A
- EVGN N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- BIVI Health Care
- EVGN Industrials
- Exchange
- BIVI Nasdaq
- EVGN Nasdaq
- Market Cap
- BIVI 11.9M
- EVGN 11.6M
- IPO Year
- BIVI N/A
- EVGN N/A
- Fundamental
- Price
- BIVI $1.82
- EVGN $1.21
- Analyst Decision
- BIVI
- EVGN Strong Buy
- Analyst Count
- BIVI 0
- EVGN 1
- Target Price
- BIVI N/A
- EVGN $3.50
- AVG Volume (30 Days)
- BIVI 323.5K
- EVGN 46.1K
- Earning Date
- BIVI 11-12-2025
- EVGN 08-19-2025
- Dividend Yield
- BIVI N/A
- EVGN N/A
- EPS Growth
- BIVI N/A
- EVGN N/A
- EPS
- BIVI N/A
- EVGN N/A
- Revenue
- BIVI N/A
- EVGN $9,444,000.00
- Revenue This Year
- BIVI N/A
- EVGN N/A
- Revenue Next Year
- BIVI N/A
- EVGN $63.64
- P/E Ratio
- BIVI N/A
- EVGN N/A
- Revenue Growth
- BIVI N/A
- EVGN N/A
- 52 Week Low
- BIVI $1.42
- EVGN $0.95
- 52 Week High
- BIVI $75.00
- EVGN $3.32
- Technical
- Relative Strength Index (RSI)
- BIVI 33.82
- EVGN 44.64
- Support Level
- BIVI $1.54
- EVGN $1.16
- Resistance Level
- BIVI $2.03
- EVGN $1.29
- Average True Range (ATR)
- BIVI 0.15
- EVGN 0.06
- MACD
- BIVI 0.23
- EVGN -0.00
- Stochastic Oscillator
- BIVI 65.57
- EVGN 29.41
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.